» Authors » Matthew Danter

Matthew Danter

Explore the profile of Matthew Danter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 146
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehta H, Gheith Z, Amin S, Acharya P, Daon E, Downey P, et al.
Kans J Med . 2024 Jun; 17:45-50. PMID: 38859990
Introduction: Traumatic cardiac injury (TCI) poses a significant risk of morbidity and mortality, yet there is a lack of population-based outcomes data for these patients. Methods: The authors examined national...
2.
Vasudeva R, Mehta H, Chan W, Majmundar M, Yarlagadda S, Downey P, et al.
Am J Cardiol . 2024 Apr; 210:37-43. PMID: 38682717
Patients with end-stage kidney disease (ESKD) on dialysis have an increased burden of coronary artery disease (CAD). This study assessed the trend and outcomes for coronary artery bypass surgery (CABG)...
3.
Nuqali A, Goyal A, Acharya P, Mastoris I, Dalia T, Chan W, et al.
Am Heart J Plus . 2024 Apr; 13:100076. PMID: 38560058
Background: There is a paucity of data on readmission rates and predictors of readmissions in cardiogenic shock patients after contemporary Extracorporeal Membrane Oxygenation (ECMO) use. Methods: Using the Nationwide Readmission...
4.
Mehra M, Netuka I, Uriel N, Katz J, Pagani F, Jorde U, et al.
JAMA . 2023 Nov; 330(22):2171-2181. PMID: 37950897
Importance: Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet...
5.
Dalia T, Chan W, Sauer A, Ranka S, Goyal A, Mastoris I, et al.
J Card Fail . 2022 Apr; 28(11):1604-1614. PMID: 35470059
Background: There is paucity of data regarding durable left ventricular assist device (LVAD) outcomes in patients with chronic kidney disease (CKD) stages 3-5 and CKD stage 5 on dialysis (end-stage...
6.
Ellis C, Badhwar N, Tschopp D, Danter M, Jackson G, Kerendi F, et al.
JACC Clin Electrophysiol . 2020 Dec; 6(13):1603-1615. PMID: 33334437
Objectives: The aim of this study was to assess the safety and efficacy of a new subxiphoid hybrid epicardial-endocardial atrial fibrillation (AF) ablation and left atrial appendage (LAA) ligation approach...
7.
Zalawadiya S, Lindenfeld J, Shah A, Wigger M, Danter M, Brinkley D, et al.
ASAIO J . 2019 Aug; 66(5):553-558. PMID: 31425256
Donor-derived hepatitis C (dd-HCV) infection may increase the risk of renal impairment (RI) among heart transplantation (HT) recipients. Sofosbuvir, an integral component of HCV direct-acting antivirals (DAAs) has also been...
8.
McGee Jr E, Danter M, Strueber M, Mahr C, Mokadam N, Wieselthaler G, et al.
J Heart Lung Transplant . 2019 Apr; 38(4):344-351. PMID: 30945636
Background: The HeartWare centrifugal-flow ventricular assist device system (HVAD) is a viable option for treatment of advanced heart failure. There is a growing trend toward the use of less invasive...
9.
Menachem J, Lindenfeld J, Schlendorf K, Shah A, Bichell D, Book W, et al.
J Heart Lung Transplant . 2018 Sep; 37(11):1351-1360. PMID: 30174166
Background: The number of adult congenital heart disease (ACHD) patients requiring heart transplantation (HT) continues to grow, and if they survive the first year after transplant, their long-term survival is...
10.
Moretz J, Lindenfeld J, Shah A, Wigger M, Schlendorf K, Keebler M, et al.
ASAIO J . 2018 Aug; 65(7):649-655. PMID: 30153198
Anticoagulation reversal agents (ARAs) can minimize bleeding complications associated with mechanical circulatory support devices (MCSDs) explantation at the time of heart transplantation (HT); data on thromboembolic (TE) risk associated with...